Chronomodulated drug delivery system: A comprehensive review on the recent advances in a new sub-discipline of chronopharmaceutics

Asian Journal of Pharmaceutics

Volumn 5, Issue 1, 2011, Pages 1-8

  Bisht, Rohit ^a  

^a Siddhartha Institute of Pharmacy   (India)

Author keywords

Chronobiology; chronopharmacodynamics; circadian rhythm; drug delivery system; mechanism; pulsatile drug delivery; suprachiasmatic nuclei

Indexed keywords

ALKANOL; CARDIZEMR; CELLULOSE; CETOSTEARYLIC ALCOHOL; DILTIAZEM; ETHYL CELLULOSE; EXCIPIENT; MACROGOL; MICROSPHERE; PLASTICIZER; POLYMER; PROPRANOLOL; PULSINCAP; UNCLASSIFIED DRUG;

CHRONOPHARMACEUTICS; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DISEASE ACTIVITY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; INFUSION PUMP; OSMOSIS; PHYSICAL CHEMISTRY; REVIEW; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; TABLET FORMULATION; TECHNOLOGY;

EID: 79960265714     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.80057     Document Type: Review

References (99)

1. Halberg F, Stephens AN. Susceptibility to ouabain and physiologic circadian periodicity. Proc Minn Acad Sci 1959;27:139-43.
2. Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 1997;91:1055-64. (Pubitemid 28027837)
3. Tei H, Okamura H, Shigeyoshi Y, Fukuhara C, Ozawa K, Hirose M, et al. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 1997;389:512-6. (Pubitemid 27435329)
4. Takumi T, Taguchi K, Miyake S, Sakakida Y, Takashima N, Matsubara C, et al. A light independent oscillatory gene mPer3 in mouse SCN and OVLT. EMBO J 1998;17:4753-9. (Pubitemid 28377175)
5. Gekakis N, Staknis D, Nguyen HB, Davis FC, Wilsbacher LD, King DP, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-9. (Pubitemid 28277694)
6. Ikeda M, Nomura M. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS protein (BMAL1) and identification of alternatively spliced variants with alternative translation initiation site usage. Biochem Biophys Res Commun 1997;233:258-64. (Pubitemid 27215947)
7. Sangoram AM, Saez L, Antoch MP, Gekakis N, Staknis D, Whiteley A, et al. Mammalian circadian autoregulatory loop: A timeless ortholog and mPER1 interact and negatively regulate CLOCKBMAL1- induced transcription. Neuron 1998;21:1101-13. (Pubitemid 29018079)
8. Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, Muijtjens M, et al. Photic induction of mPer1 and mPer2 in Crydeficient mice lacking a biological clock. Science 1999;286:2531-4.
9. Lowrey PL, Shimomura K, Antoch MP, Yamazaks S, Zemenides PD, Ralph MR, et al. Positional systemic cloning and functional characterization of the mammalian circadian mutation tau. Science 2000;288:483-92.
10. Tei H, Okamura H, Shigeyoshi Y, Fukuhara C, Ozawa K, Hirose M, et al. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 1997;389:512-6. (Pubitemid 27435329)
11. Bussemer T, Peppas NA, Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm. Biopharm 2003;56:261-70. (Pubitemid 37072111)
12. Martin RJ, Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med 1998;158:1002-7. (Pubitemid 28449474)
13. Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. Adv Drug Deliv. Rev 2007;59:883-95. (Pubitemid 47531899)
14. Morta R, Jose L, Vila J. Design of new multiparticulate sysmem for potential site-specific and controlled drug delivery to the colonic region. J Contr Rel 1998;55:67-77.
15. Richard JM, Susan BS. Chronobiology of asthma. Am J Resp Crit Care Med. 1998;158:1002-7. Available from: http://www.atsjournals.org.[Last accessed on 2010 Dec 02].
16. Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release 2001;73:103-10. (Pubitemid 32409351)
17. Mohamad A, Dashevsky A. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD. Eur J Pharm Biopharm 2006;64:173-9. (Pubitemid 44291988)
18. Gazzaniga A, Maroni A, Sangalli ME, Zema L. Time-controlled oral delivery systems for colon targeting. Exp Opin. Drug Deliv 2006;5:583-97. (Pubitemid 44383487)
19. Khan Z, Pillay V, Choonara YE, du Toit LC. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol 2009;14:602-12.
20. Saigal N, Baboota S, Ahuja A, Ali J. Multiple pulse drug delivery systems: Setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv 2009;6:441-52.
21. Sawada T, Sako K, Yoshihara K, Nakamura K, Yokohama S, Hayashi M. Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam. J Pharm Sci 2003;92:790-7. (Pubitemid 36396995)
22. Stevens H, Chariot M, Arnold F, Lewis G. Sustained release pharmaceutical composition of diltiazem. U.S. patent 5112621, May 12, 1992.
23. Halberg F. Chronobiology. Annu Rev Physiol 1969;31:675-725.
24. Reinberg A, Halberg F. Circadian chronopharmacology. Annu Rev Pharmacol 1971;11:455-92.
25. Smolensky MH, Labrecque G. Chronotherapeutics. Pharm News 1997;4:10-6.
26. Ohdo S. Changes in toxicity and effectiveness with timing of drug administration. Implications for drug safety. Drug Safety 2003;26:999-1010. (Pubitemid 37452642)
27. Ohdo S. Chronopharmaceutics: Pharmaceutics focused on biological rhythm. Biol Pharm Bull 2010;33:159-67.
28. Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet 2007; 22:3-14.
29. Moore JG, Englert E Jr. Circadian rhythm of gastric acid secretion in man. Nature 1970;226:1261-2.
30. Bloom PB, Filion RD, Stunkard AJ, Fox S, Stellar E. Gastric and duodenal motility, food intake and hunger measured in man during a 24-h period. Am J Dig Dis 1970;15:719-25.
31. Belanger P, Bruguerolle B, Labrecque G. Rhythms in pharmacokinetics: Absorption, distribution, metabolism and excretion. In: Redfern PH, Lemmer B, editors. Physiology and Pharmacology of Biological Rhythms. Heidelberg: Springer-Verlag; 1997. p. 177-204.
32. Labrecque G, Belanger P. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 1991;52:95-107.
33. Reinberg A, Smolensky M. Circadian changes of drug disposition in man. Clin Pharmacokinet 1982;7:401-20. (Pubitemid 12057029)
34. Bruguerolle B. Chronopharmacokinetics: Current status. Clin Pharmacokinet 1998;35:83-94. (Pubitemid 28379423)
35. Labrecque G, Belanger P. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 1991;52:95-107.
36. Anderson NH, Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL, et al. Telemetry for cardiovascular monitoring in a pharmacological study: New approaches to data analysis. Hypertension 1999;33:248-55. (Pubitemid 29065667)
37. Pleschka K, Heinrich A, Witte K, Lemmer B. Diurnal and seasonal changes in sympathetic signal transduction in cardiac ventricles of European hamsters. Am J Physiol 1996;270:304-9.
38. Bruguerolle B, Arnaud C, Levi F, Focan C, Touitou Y, Bouvenot G. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: Implications for chronopharmacology. In: Baumann P, C.B. Chronobiol Int 2008; 25(1):1-15
39. Feuers RJ, Scheving LE. Chronobiology of hepatic enzymes. Ann Rev Chronopharmacol 1988;4:209-54.
40. Belanger PM, Labrecque G. Temporal aspects of drug metabolism. In: Lemmer B, editor. Chronopharmacology: Cellular and Biochemical Interactions. Basel: Marcel Dekker; 1991. p. 15-34.
41. Ohno M, Yamaguchi I, Ito T, Saiki K, Yamamoto I, Azuma J. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: Implications for chronopharmacology. Circadian variation of the urinary 6 beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 2000;55:861-5. (Pubitemid 30201769)
42. Cambar J, Cal JC, Tranchot J. Renal excretion: Rhythms in physiology and pathology. In: Touitou Y, Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: Implications for chronopharmacology. Haus E, editors. Biological Rhythms in Clinical and Laboratory Medicine. Paris: Springer-Verlag; 1992. p. 470-82.
43. Detli L, Spring P. Diurnal variations in the elimination rate of sulphonamide in man. Helv Med Acta 1966;4:921-926.
44. Sydenham T. The Works of Thomas Sydenham. Translated from the Latin by Lathan RG, editor. Vol. 2. London, Sydenhm socity. 1850. p. 124.
45. Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia Am Fam Phys 1999;59:925-34.
46. Rigas B, Torosis J, McDougall CJ, Vener KJ, Spiro HM. The circadian rhythm of biliary colic. J Clin Gastroenterol 1990;12:409-14. (Pubitemid 20234370)
47. Moore JG, Halberg F. Circadian rhythm of gastric acid secretion in active duodenal ulcer: Chronobiological statistical characteristics and comparison of acid secretory and plasma gastrin patterns in healthy and post-vagotomy and pyloroplasty patients. Chronobiol Int 1987;4:101-10. (Pubitemid 17096307)
48. Cugini P, Di Palma L, Battisti P, Leone G, Materia E, Parenzi A, et al. circadian and infradian periodicity of some cardiovascular emergencies. Am J Cardiol. 1990;66:240-243. (Pubitemid 20235742)
49. Kroetz CO, Ein biologiescher 24-Studen-Rhythmus des Blutkreislaufs bei Gesundheit und bei Herzschivache zugleich ein Beitrag zur tageszeitlichen Haufung einiger akuter Kreislaufstorunge. Munch Med Wochenschr. 1940;87:314-7.
50. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1998;85:6-8.
51. Bateman JR, Clark SW. Sudden death in asthma. Thorax 1979;34:40-4. (Pubitemid 9138530)
52. Kelmanson IA. Circadian variation of the frequency of sudden infant death syndrome and of sudden death from life-threatening conditions in infants. Chronobiologia 1991;18:181-6.
53. Reinberg AE, Gervais P, Levi F, Smolensky M, Del Cerro L, Ugolini C. Circadian and circannual rhythms of allergic rhinitis: An epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol 1988;81:51-62. (Pubitemid 18057597)
54. Smolensky MH, Reinberg A, Labrecque G.Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: Treatment implications. J Allergy Clin Immunol 1995;95:1084-96.
55. Kowanko IC, Knapp MS, Pownall R, Swannell AJ. Domiciliary self measurement in rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann Rheum Dis 1982;41:453-5. (Pubitemid 12035488)
56. Solomon GD. Circadian rhythms and migraine. Clevel Clin J Med 1992;59:326-9.
57. Dexter JD, Weizman ED. The relationship between nocturnal headaches to sleep stage patterns. Neurology 1970;20:513-8.
58. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, et al, Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400. (Pubitemid 17007346)
59. Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A, et al, Circadian variation of total ischemic burden and its alteration with anti-anginal agents. Lancet 1998;2:755-9.
60. Behrens S, Ehlers C, Brggemann T, Ziss W, Dissmann R, Galecka M, et al. Modification of the circadian pattern of ventricular tachyarrthythmias by beta-blocker therapy. Clin Cardiol1997;20:253-7.
61. Goldstein S, Zoble RG, Akiyama T, Cohen JD, Lancaster S, Liebson PR, et al, Relation of circadian ventricular ectopic activity to cardiac mortality CAST Investigators. Am J Cardiol 1996;78:881-5. (Pubitemid 126658647)
62. Venditti FJ Jr, John RM, Hull M, Tofler GH, Shahian DM, Martin DT. Circadian variation in defibrillation energy requirements. Circulation 1996;94:1607-12. (Pubitemid 26320265)
63. Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997;79:1512-6. (Pubitemid 27251072)
64. Elliott WJ. Circadian variation in the timing of stoke onset. A meta analysis. Stroke 1998;29:992-6. (Pubitemid 28228162)
65. Gallerani M, Manfredini R, Ricci L, Grandi E, Cappato R, Cal G. Sudden death from pulmonary thromboembolism: Chronobiological aspects. Eur Heart J 1992;6:305-23.
66. Gallerani M, Manfredini R, Fersini C. Chronoepidemiology in human disease. Ann Inst Super Sanita 1993;29:569-79.
67. Portaluppi F, Manfredini R, Fersini C. From a static to a dynamic concept of risk: The circadian epidemiology of cardiovascular risk. Chronobiol Int 1999;16:33-50.
68. Wehr TA. Circadian rhythm disturbances in depression and mania. In: Brown FM, Graeber RC, editors. Rhythmic Aspects of Behavior. New Jerey. Lawrence Erlbaum Ass; 1982. p. 399-428.
69. Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. J Rheumatol 1990;17:364-72. (Pubitemid 20106616)
70. Folkard S. Diurnal variation and individual differences in the perception of intractable pain. J Psychosom Res 1976;20:289-304.
71. Manfredini R, Gallerani M, Salmi R, Cal G, Pasin M, Bigoni M. Circadian variation in the time of onset of acute intestinal bleeding. J Emerg Med 1994;12:5-9. (Pubitemid 24100181)
72. Svanes C, Sothern RB, Sorbye H. Rhythmic patterns in incidence of peptic ulcer perforation over 5.5 decades in Norway. Chronobiol Int 1998;15:241-264. (Pubitemid 28305559)
73. Langdon-Down M, Brain WR. Time of day in relation to convulsion in epilepsy. Lancet 1929;12:1029-1032.
74. Baxil CW, Walczak TS. Effects of sleep and sleep stage on epileptic and nonepileptic seizures. Epilepsia 1997;38:56-62. (Pubitemid 27057481)
75. Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med 2001;7:356-60. (Pubitemid 32224353)
76. Youan BC. Chronopharmaceutics: Gimmick or clinically relevant approach to drug delivery?. J Control Rel 2004;98:337-53.
77. Jao F, Wong P, Huynh H, McChesney K, Wat P. United States: Alza Corporation. 1992. p. 17.
78. Verma R, Sanjay G. Current status of drug delivery technologies and future directions. Pharm Technol 2001;25:1-14.
79. Leslie S. Euroceltique, SA, United States: 1982. p. 20.
80. Leslie S. The Contin delivery system: Dosing considerations. J Allergy Clin Immunol 1986;78:768-73. (Pubitemid 17170594)
81. Arkinstall WW. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma. Am J Med 1988;85:60-3.
82. Percel P, Vishnupad K, Venkatesh GM. Timed pulsatile drug delivery systems. US Patent 6,627,223.
83. FDA. In: Electronic Orange Book. Washington, DC: Electronic Orange Book; 2003.
84. Youan BC. Overview of chronopharmaceutics. In: Youan BC, Editor. Chronopharmaceutics: Science and Technology for Biological Rhythm Guided Therapy and Prevention of Diseases. Hoboken, NJ: John Wiley and Sons, Inc; 2009.
85. Prisant LM, Devane JG, Butler J. A steady-state evaluation of the bioavailability of chronopharmaceutic oral drug absorption system verapamil PM after night time dosing versus immediate-acting verapamil dosed every 8 h. Am J Ther 2000;7:345-51.
86. Panoz D, Geoghegan E. Elan Corporation, United States, 1989. p. 49.
87. Conte U, Maggi L. Modulation of the dissolution profiles from Geomatrix multilayer matrix tablets containing drugs of different solubility. Biomoterials 1996;17:889-96. (Pubitemid 26136568)
88. Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, et al, Oral dosage forms fabricated by three dimensional printing. J Control Release 2000;66:1-9. (Pubitemid 30116679)
89. Rowe CW, Katstra WE, Palazzolo RD, Giritlioglu B, Teung P, et al, Multimechanism oral dosage forms fabricated by three dimensional printing. J Control Release 2000;66:11-7. (Pubitemid 30116680)
90. Monkhouse D, Yoo J, Sherwood J, Cima M, Bornancini E. Therics. United States, 2003. p. 19.
91. Staniforth JN, Baichwal AR, TIMERx : Novel polysaccharide composites for controlled/programmed release of drugs in the gastrointestinal tract. Expert Opin Drug Deliv 2005;2:587-95. (Pubitemid 41683230)
92. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75-87.
93. Mahey R, Bersot T. Drug therapy for hypercholesterolemia and dyslipidemia. In: Hardman J, Limbird L, Gilman A, editors. Goodman and Gilmans The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 2001.
94. Santini JT Jr, Cima MJ, Langer R. A controlled-release microchip. Nature 1999;397:335-8. (Pubitemid 29061643)
95. Santini JT Jr, Richards AC, Scheidt R, Cima MJ, Langer R. Microchips as controlled drug-delivery devices. Angew Chem Int Ed Engl 2000;39:2396-407. (Pubitemid 30602505)
96. Sershen S, West J. Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv 2002;54:1225-35. (Pubitemid 35223419)
97. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997;350:681-6. (Pubitemid 27371165)
98. Remeling R, Hrushesky WJ. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. J Clin Oncol 1989;7:1710-9. (Pubitemid 19272843)
99. Tzannis ST, Hrushesky WJ, Wood PA, Przybycien TM. Irreversible inactivation of interleukin 2 in a pump-based delivery environment. Proc Natl Acad Sci USA 1996;93:5460-5. (Pubitemid 26159472)